Results 181 to 190 of about 578,573 (268)

Phthalate Metabolite, Mono(2‐Ethyl‐5‐Hydroxyhexyl) Phthalate (MEHHP), Promotes Uterine‐Fibroid–Associated Phenotypes in Myometrial Stem Cell‐Derived 3D Organoids

Environmental Toxicology, Volume 41, Issue 10, Page 975-997, October 2026.
ABSTRACT This study investigates how phthalate exposure contributes to uterine fibroid (UF) development by studying the effects of the Mono‐(2‐ethyl‐5‐hydroxyhexyl) phthalate (MEHHP), a metabolite of Di(2‐ethylhexyl) phthalate, on myometrial stem cells (MMSCs).
Somayeh Vafaei, Mervat M. Omran, Qiwei Yang, Sandra Madueke‐Laveaux, Ami R. Zota, Ayman Al‐Hendy, Mohamed Ali   +6 more
wiley   +1 more source

Global ecological associations between overweight/obesity and non-communicable disease prevalence among children aged 5-9 years: a sex-stratified analysis of 174 countries. [PDF]

Front Public Health
Ye W, Shi L, Ye S, Wen Y, Gong J, Qian W, Zhang L, Lu L.   +7 more
europepmc   +1 more source

Psychiatric disorders and gynecologic tumors: A 2-sample Mendelian randomization study of 20 exposure-outcome pairs. [PDF]

Medicine (Baltimore)
Zheng P, Chen W, Jiang M.
europepmc   +1 more source

Genital Tract and Circulating CD8+ T Cell Phenotypes Vary Across the Menstrual Cycle

American Journal of Reproductive Immunology, Volume 96, Issue 4, October 2026.
ABSTRACT Problem The menstrual cycle consists of two main phases: the follicular phase, characterized by rising estradiol and low progesterone, and the luteal phase, marked by elevated progesterone following ovulation. Changes in sex hormones have profound physiological effects, yet their impact on immunity remains poorly understood.
Irene Cruz Talavera, Katherine K. Thomas, Jessica B. Graham, Jessica L. Swarts, Sarah C. Vick, Finn MacLean, Nicole B. Potchen, Lakshmi Warrier, Adino Tesfahun Tsegaye, Sean M. Hughes, Florian Hladik, Bhavna H. Chohan, Kenneth Ngure, Nelly Mugo, Jairam R. Lingappa, Jennifer M. Lund, for the Kinga Study Team   +16 more
wiley   +1 more source

Prognostic biomarkers associated with the progression of cervical lesions to cervical cancer: a scoping review.

The objective of this scoping review is to provide a comprehensive overview of the relationship between the expression of prognostic biomarkers associated with the progression of high-grade intraepithelial lesions to cervical cancer by identifying gaps ...
Luis Gabriel Giraldo Barrios
core   +1 more source

Lymphoma of the cervix invading the uterine body with distant lymphadenopathy: MRI and FDG-PET/CT findings. [PDF]

Radiol Case Rep
Vu I, Vu P, Byun T, Stelling A.
europepmc   +1 more source

NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2

Cancer Science, Volume 117, Issue 10, Page 2803-2818, October 2026.
Copy number variation analysis in The Cancer Genome Atlas identified NTAQ1 as a potential driver of HCC progression. NTAQ1 accelerates tumor growth by promoting the degradation of the tumor suppressor protein PRDM2, thereby impairing DNA repair and suppressing apoptosis. These findings indicate that NTAQ1 could be a valuable target for the treatment of
Tomohiko Ikehara, Hajime Otsu, Taro Tobo, Kiyotaka Hosoda, Tadashi Abe, Masahiro Hashimoto, Yusuke Nakano, Katsushi Dairaku, Yuya Ono, Yuki Miyata, Chihiro Matsumoto, Takanari Tatsumi, Satoshi Higuchi, Takashi Ofuchi, Akinori Tsujimoto, Yuki Ando, Qingjiang Hu, Yusuke Yonemura, Akira Shimizu, Takaaki Masuda, Yuji Soejima, Koshi Mimori   +21 more
wiley   +1 more source

Case Report: Clinical analysis and literature review of two cases of high-grade adult-type cervical embryonal rhabdomyosarcoma. [PDF]

Front Oncol
Song W, Li T, Chen Y, Yao Q, Song K.
europepmc   +1 more source

Tissue Factor‐High Ovarian Clear Cell Carcinoma Shows Immune‐Cold Features and Preclinical Activity of Tisotumab Vedotin

Cancer Science, Volume 117, Issue 10, Page 2838-2851, October 2026.
F3/TF‐high ovarian clear cell carcinoma exhibits an immune‐cold phenotype characterized by reduced immune‐cell fractions and attenuated cancer‐cell interferon programs, with frequent B7‐H4 co‐expression. Patient‐derived models show preclinical sensitivity to the TF‐directed antibody–drug conjugate tisotumab vedotin.
Yutaro Mori, Ryo Tamura, Kotaro Takahashi, Kaoru Yamawaki, Tatsuya Ishiguro, Teiichi Motoyama, Koji Okamoto, Kosuke Yoshihara   +7 more
wiley   +1 more source

Synchronous Ovarian and Cervical Malignancies: A Case Report of Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and Niraparib Maintenance. [PDF]

Int J Womens Health
Lv X, Tang L, Ma Y, Zhou L.
europepmc   +1 more source